Persistent eczema leads to both impaired growth and food allergy: JECS birth cohort.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
13
09
2021
accepted:
10
11
2021
entrez:
1
12
2021
pubmed:
2
12
2021
medline:
4
1
2022
Statut:
epublish
Résumé
Skin inflammation leads to altered cytokine/chemokine production and causes systemic inflammation. The systemic mechanism of atopic dermatitis (AD) is recognized to affect systemic metabolism. This study aimed to examine the relationship between early-onset persistent eczema and body weight, height, and body mass index (BMI), in addition to food allergy in a birth cohort among infants. This study design was a nationwide, multicenter, prospective birth cohort study-the Japan Environment and Children's Study (JECS). Generalized linear models were fitted for z scores of weight, height, BMI, and food allergy to evaluate the relationship between eczema and these outcomes for infants at age1, 2, and 3 years. Persistent eczema was negatively associated with height at the age of 2 years (estimated coefficient, -0.127; 95% confidence interval [CI], -0.16 to -0.095) and 3 years (-0.177; 95% CI, -0.214 to -0.139). The same tendency was also observed with weight and BMI. Early disease onset at younger than 1 year and persistent eczema had the strongest association with development of food allergy at age 3 years (OR, 11.794; 95% CI, 10.721-12.975). One phenotype of eczema with early-onset and persistent disease creates a risk of both physical growth impairment and development of food allergy. Infants who present with the early-onset and persistent type of eczema should be carefully evaluated daily for impaired physical growth and development of food allergy.
Identifiants
pubmed: 34851995
doi: 10.1371/journal.pone.0260447
pii: PONE-D-21-29612
pmc: PMC8635351
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0260447Déclaration de conflit d'intérêts
The authors declare that they have no competing interests related to the contents of this study.
Références
Inflamm Res. 2017 Oct;66(10):833-842
pubmed: 28620798
Clin Pediatr Endocrinol. 2016 Apr;25(2):71-6
pubmed: 27212799
BMC Psychiatry. 2017 Mar 31;17(1):120
pubmed: 28359274
J Invest Dermatol. 2017 Jan;137(1):18-25
pubmed: 27771048
Clin Exp Allergy. 2015 Jan;45(1):255-64
pubmed: 25210971
BMC Public Health. 2014 Jan 10;14:25
pubmed: 24410977
J Dermatol Sci. 2016 Nov;84(2):144-148
pubmed: 27523805
Clin Pediatr Endocrinol. 2011 Apr;20(2):47-9
pubmed: 23926394
Allergol Int. 2019 Oct;68(4):521-523
pubmed: 30935805
J Am Acad Dermatol. 2015 Apr;72(4):606-16.e4
pubmed: 25773409
J Eur Acad Dermatol Venereol. 2021 Nov;35(11):2166-2184
pubmed: 33988873
World Allergy Organ J. 2020 Nov 07;13(11):100479
pubmed: 33204389
Pediatr Allergy Immunol. 2002 Aug;13(4):287-94
pubmed: 12390445
J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1421-1424.e2
pubmed: 29366732
Eur J Clin Nutr. 1990 Jan;44(1):45-60
pubmed: 2354692
Ann Allergy Asthma Immunol. 2021 Jun;126(6):713-721.e1
pubmed: 33639261
JAMA Pediatr. 2017 Jul 1;171(7):655-662
pubmed: 28531273
BMC Dermatol. 2020 Sep 22;20(1):8
pubmed: 32962676
J Eur Acad Dermatol Venereol. 2020 Dec;34(12):2717-2744
pubmed: 33205485